A phase II trial of gemcitabine (G), cisplatin (C), and nab-paclitaxel (N) in advanced biliary tract cancers (aBTCs).

被引：7
|
作者：
Shroff, Rachna T.
Borad, Mitesh J.
Xiao, Lianchun
Kaseb, Ahmed Omar
Varadhachary, Gauri R.
Wolff, Robert A.
Raghav, Kanwal Pratap Singh
Iwasaki, Michiko
Masci, Peter
Ramanathan, Ramesh K.
Ahn, Daniel H.
Bekaii-Saab, Tanios S.
Javle, Milind M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, GI Med Oncol Dept, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[6] Mayo Clin Arizona, Scottsdale, AZ USA
[7] Mayo Clin, Canc Ctr, Phoenix, AZ USA
[8] Univ Texas MD Anderson Canc Ctr, Gastrointestinal Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.4018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4018
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer
    Mahipal, Amit
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Goyal, Gaurav
    Soares, Heloisa
    Neuger, Anthony
    Copolla, Domenico
    Kim, Jongphil
    Kim, Richard
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (03) : 473 - 481
  • [32] Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer
    Amit Mahipal
    Sri Harsha Tella
    Anuhya Kommalapati
    Gaurav Goyal
    Heloisa Soares
    Anthony Neuger
    Domenico Copolla
    Jongphil Kim
    Richard Kim
    Investigational New Drugs, 2019, 37 : 473 - 481
  • [33] Nab-paclitaxel plus capecitabine as first-line treatment for advanced biliary tract cancers: An open-label, non-randomized, phase II clinical trial
    Xu, Ling-Xiao
    Yuan, Jia-Jia
    Xue, Ran
    Zhou, Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (30)
  • [34] A phase II trial of nab-paclitaxel (NP) in patients with advanced pancreatic cancer (PC) who have progressed on gemcitabine (G)-based therapy
    Hosein, P. J.
    Lopes, G. D., Jr.
    Gomez, C. M.
    Pastorini, V. H.
    Macintyre, J.
    Easey, M.
    Reis, I. M.
    Merchan, J. R.
    Bejarano, P.
    Lima, C. S. Rocha
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Phase II trial of biologically optimized schedule of gemcitabine and nab-paclitaxel in metastatic pancreatic cancer
    Noonan, Anne M.
    Noonan, Anne M.
    Abushahin, Laith I.
    Wei, Lai
    Malalur, Pannaga G.
    Manne, Ashish
    Mittra, Arjun
    Roychowdhury, Sameek
    Jin, Ning
    Hays, John L.
    Babcook, Melissa A.
    Risch, Zachary
    Rahman, Shafia
    Hazard, Brooke
    Williams, Terence Marques
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] Interim results of a multicenter phase II trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC).
    Lacy, Jill
    Portales, Fabienne
    Hammel, Pascal
    Cid, Roberto A. Pazo
    Mozo, Jose Luis Manzano
    Kim, Edward Jae-hoon
    Dowden, Scot D.
    Borg, Christophe
    Sastre, Javier
    Bathini, Venu Gopal
    Terrebonne, Eric
    Lopez-Trabada, Daniel
    Rivera, Fernando
    Asselah, Jamil
    Damiani, Azzurra
    Hwang, Jimmy J.
    Ong, Teng Jin
    Nydam, Thom
    Li, Jack Shiansong
    Philip, Philip Agop
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [37] Nab-paclitaxel plus capecitabine as a first-line regimen for advanced biliary tract cancers: Feasible or not feasible?
    Chen, Jian-Qiang
    Lan, Xiang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2025, 31 (10)
  • [38] Real-World Outcomes of Gemcitabine, Cisplatin, and Nab-Paclitaxel Chemotherapy Regimen for Advanced Biliary Tract Cancer: A Propensity Score-Matched Analysis
    Jung, Kwangrok
    Park, Jaewoo
    Jung, Jae Hyup
    Lee, Jong-Chan
    Kim, Jaihwan
    Hwang, Jin-Hyeok
    GUT AND LIVER, 2022, 16 (05) : 798 - 805
  • [39] Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers
    Tan, Elaine S.
    Cao, Biwei
    Kim, Jongphil
    Al-Toubah, Taymeyah E.
    Mehta, Rutika
    Centeno, Barbara A.
    Kim, Richard D.
    CANCER, 2021, 127 (08) : 1293 - 1300
  • [40] A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma
    Ke, Liang-Ru
    Xia, Wei-Xiong
    Qiu, Wen-Ze
    Huang, Xin-Jun
    Yu, Ya-Hui
    Liang, Hu
    Liu, Guo-Ying
    Xiang, Yan-Qun
    Guo, Xiang
    Lv, Xing
    ORAL ONCOLOGY, 2017, 70 : 7 - 13
12345